Evidence map›Paper›PMID 35649384›Full record

ArticlePathobiology : journal of immunopathology, molecular and cellular biology2023

Sustained Inflammation of Breast Tumors after Needle Biopsy.

Cruz McCarty, Misung Yi, Senna Sous, Macall Leslie, Ezza Tariq, Priya Dondapati, Hiroyasu Kameyama, Shreya Nuguri, Natalie Chakraborty, Marielle Wilkerson and 6 more

Open access · hybridAbstract read
In one paragraph

Article in Pathobiology : journal of immunopathology, molecular and cellular biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 1 country.

Cruz McCartySchool of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Misung YiDivision of Biostatistics, Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Senna SousSchool of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Macall LeslieStephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Ezza TariqStephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Priya DondapatiStephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Hiroyasu KameyamaStephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Shreya NuguriSchool of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Natalie ChakrabortySchool of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Marielle WilkersonSchool of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Rachel DavisDepartment of General Surgery, School of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Sidra MesiyaSchool of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Hallgeir RuiDepartment of Pathology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Inna ChervonevaDivision of Biostatistics, Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Roy ZhangDepartment of Pathology, School of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Takemi TanakaStephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
University of Oklahoma Health Sciences Center · USThomas Jefferson University · USMedical College of Wisconsin · US

Funding

Tissue Pathology Shared ResourceP30CA225520 · NCI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Wade Williams · 2018 to 2026
$27.1M
NCI NIH HHS P30 CA225520
6 · The paper itself

Abstract

introductionNeedle biopsy is essential for definitive diagnosis of breast malignancy. Significant histologic changes due to tissue damage have been reported in solid tumors. This study investigated the association between time from needle biopsy and inflammation in breast tumors.

methodsA total of 73 stage I-II invasive breast cancer cases diagnosed by image-guided needle biopsy who had surgery as their first definitive treatment were retrospectively analyzed. Time from biopsy to surgical excision ranged from 8 to 252 days. Histological sections of surgically resected tumors with a visible needle tract were reviewed by histologic evaluation. Data were analyzed by McNemar's test for proportional differences, and the Benjamini-Hochberg procedure was used to assess the association between immune cell prevalence and clinical variables.

resultsCharacteristic histology changes, including foreign body giant-cell reaction, synovial-cell metaplasia, desmoplastic repair changes, granulation tissue, fat necrosis, and inflammation, were frequently detected adjacent to the needle tract. Spatial comparison indicated that a higher proportion of cases had neutrophils, eosinophils, and macrophages adjacent to the needle tract than tumors distant from it. The presence of inflammatory cells adjacent to the needle tract was not associated with time from biopsy or subtype. Still, plasma cells were associated with residual carrier material from biopsy markers.

conclusionMacrophages and eosinophils are highly abundant and retained adjacent to the needle tract regardless of time from the biopsy.

Indexed as

Breast NeoplasmsBiopsy, NeedleBreastFemaleHumansRetrospective StudiesBreast cancerNeedle biopsyPost-biopsy change

Identifiers

PMID35649384
PMCPMC10874194
OpenAlexW4281742888

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.